SCHEMBL24287510

SCHEMBL24287510

Cc1ccccc1Oc1nc2ccccc2nc1N[S+]([O-])c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CYP1A2 P05177 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MRGPRX1 Q96LB2 1/20 0.34
▸ LYN P07948 1/20 0.33
▸ BTK Q06187 1/20 0.33
▸ LMNA P02545 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ MAP4K4 O95819 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24287774 0.84 P2RY1 (0.40) TP53
SCHEMBL24287258 0.73 ALDH1A1 (0.50) ALDH1A1L3MBTL1SMN1; SMN2MEN1KMT2A
SCHEMBL24287425 0.73 ALDH1A1 (0.40) ALDH1A1L3MBTL1SMN1; SMN2MEN1KMT2A
SCHEMBL24287526 0.71 MAPT (0.39) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL26817474 0.71 KDM4E (0.64) ALDH1A1L3MBTL1SMN1; SMN2MEN1KMT2A
SCHEMBL14050665 0.68 MAPT (0.45) ALDH1A1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL26813123 0.65 ALDH1A1 (0.46) ALDH1A1L3MBTL1SMN1; SMN2MEN1KMT2A
SCHEMBL30901366 0.65 POLB (0.36) ALDH1A1SMN1; SMN2MEN1KMT2ATSHR
SCHEMBL24287379 0.61 LMNA (0.34) ALDH1A1L3MBTL1SMN1; SMN2MEN1KMT2A
SCHEMBL127000 0.61 TSHR (0.65) ALDH1A1SMN1; SMN2MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076629-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback